Labcorp a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Toxikon , a contract research organization delivering best-in-class nonclinical testing services. Once completed, the transaction will create a strategic footprint for Labcorp to partner with pharmaceutical and biotechnology clients in the Boston, Mass., area and bolster its strong nonclinical development portfolio.
- Read more about Labcorp to acquire Toxikon
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/labcorp-to-acquire-toxikon
No comments:
Post a Comment